Arterra Bioscience S.p.A. (BIT:ARBS)
Italy
· Delayed Price · Currency is EUR 1.970
-0.050 (-2.48%)
Feb 21, 2025, 5:36 PM CET
Arterra Bioscience Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Market Capitalization | 13 | 11 | 14 | 19 | 19 | 25 | Upgrade
|
| Market Cap Growth | -4.35% | -23.15% | -24.57% | 1.75% | -24.46% | - | Upgrade
|
| Enterprise Value | 10 | 6 | 9 | 15 | 15 | 24 | Upgrade
|
| Last Close Price | 1.97 | 1.58 | 1.97 | 2.58 | 2.54 | 3.38 | Upgrade
|
| PE Ratio | 9.75 | 10.27 | 10.17 | 17.17 | 16.90 | 28.93 | Upgrade
|
| PS Ratio | 4.02 | 3.31 | 4.00 | 4.02 | 4.49 | 7.07 | Upgrade
|
| PB Ratio | 1.38 | 1.03 | 1.37 | 2.01 | 2.29 | 3.49 | Upgrade
|
| P/TBV Ratio | 1.39 | 1.03 | 1.38 | 2.04 | 2.32 | 3.53 | Upgrade
|
| P/FCF Ratio | - | 11.51 | 11.05 | 22.27 | 136.05 | 27.85 | Upgrade
|
| P/OCF Ratio | - | 10.77 | 10.31 | 13.65 | 39.05 | 14.30 | Upgrade
|
| EV/Sales Ratio | 2.75 | 1.67 | 2.63 | 3.20 | 3.63 | 6.90 | Upgrade
|
| EV/EBITDA Ratio | 5.53 | 3.50 | 4.44 | 8.74 | 9.45 | 19.58 | Upgrade
|
| EV/EBIT Ratio | 7.83 | 5.26 | 5.91 | 12.16 | 12.60 | 25.75 | Upgrade
|
| EV/FCF Ratio | - | 5.80 | 7.27 | 17.73 | 109.95 | 27.17 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.04 | 0.05 | 0.06 | 0.10 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.19 | 0.24 | 0.23 | 0.35 | 0.51 | 0.81 | Upgrade
|
| Debt / FCF Ratio | - | 0.40 | 0.38 | 0.72 | 5.88 | 1.12 | Upgrade
|
| Asset Turnover | 0.29 | 0.27 | 0.30 | 0.43 | 0.42 | 0.49 | Upgrade
|
| Inventory Turnover | 1.53 | 1.18 | 1.40 | 2.72 | 2.54 | 3.07 | Upgrade
|
| Quick Ratio | 7.54 | 7.74 | 7.48 | 6.51 | 7.02 | 5.74 | Upgrade
|
| Current Ratio | 8.79 | 9.35 | 8.49 | 6.91 | 7.57 | 6.12 | Upgrade
|
| Return on Equity (ROE) | 13.02% | 10.14% | 14.18% | 12.58% | 14.50% | 17.73% | Upgrade
|
| Return on Assets (ROA) | 6.43% | 5.27% | 8.28% | 7.12% | 7.55% | 8.20% | Upgrade
|
| Return on Capital (ROIC) | 7.45% | 5.99% | 9.51% | 8.18% | 8.78% | 10.16% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.99% | 9.04% | 14.02% | 12.06% | 12.93% | 11.18% | Upgrade
|
| Earnings Yield | 10.25% | 9.74% | 9.83% | 5.82% | 5.92% | 3.46% | Upgrade
|
| FCF Yield | 8.68% | 9.05% | 4.49% | 0.74% | 3.59% | Upgrade
| |
| Dividend Yield | 4.95% | 6.34% | 5.08% | 1.94% | - | - | Upgrade
|
| Payout Ratio | 0.00% | 61.87% | - | - | - | 35.00% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | -30.67% | Upgrade
| |
| Total Shareholder Return | 4.95% | 6.34% | 5.08% | 1.94% | - | -30.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.